Market Whales and Their Recent Bets on AMGN Options
Market Whales and Their Recent Bets on AMGN Options
Whales with a lot of money to spend have taken a noticeably bearish stance on Amgen.
有很多钱可以花的鲸鱼对安进采取了明显的看跌立场。
Looking at options history for Amgen (NASDAQ:AMGN) we detected 17 trades.
查看安进（纳斯达克股票代码：AMGN）的期权历史记录，我们发现了17笔交易。
If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened trades with bullish expectations and 58% with bearish.
如果我们考虑每笔交易的具体情况，可以准确地说，有23％的投资者以看涨的预期开盘，58％的投资者持看跌预期。
From the overall spotted trades, 9 are puts, for a total amount of $557,464 and 8, calls, for a total amount of $303,400.
在已发现的全部交易中，有9笔是看跌期权，总额为557,464美元，8笔看涨期权，总额为303,400美元。
Expected Price Movements
预期的价格走势
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $240.0 to $310.0 for Amgen over the last 3 months.
考虑到这些合约的交易量和未平仓合约，在过去的3个月中，鲸鱼似乎一直将安进的价格定在240.0美元至310.0美元之间。
Volume & Open Interest Trends
交易量和未平仓合约趋势
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
查看交易量和未平仓合约是一种对股票进行尽职调查的有见地的方法。
This data can help you track the liquidity and interest for Amgen's options for a given strike price.
这些数据可以帮助您跟踪给定行使价下安进期权的流动性和利息。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Amgen's whale activity within a strike price range from $240.0 to $310.0 in the last 30 days.
下面，我们可以分别观察安进所有鲸鱼活动的看涨期权和未平仓合约在过去30天内在240.0美元至310.0美元之间的行使价区间内的变化。
Amgen Option Activity Analysis: Last 30 Days
安进期权活动分析：过去 30 天
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGN | PUT | SWEEP | BEARISH | 09/20/24 | $15.55 | $14.8 | $15.6 | $300.00 | $173.1K | 247 | 40 |
| AMGN | PUT | TRADE | BEARISH | 06/21/24 | $6.25 | $6.05 | $6.2 | $300.00 | $62.0K | 2.0K | 10 |
| AMGN | PUT | TRADE | BEARISH | 05/17/24 | $2.53 | $2.31 | $2.45 | $300.00 | $61.2K | 818 | 767 |
| AMGN | PUT | SWEEP | BULLISH | 05/24/24 | $6.45 | $5.5 | $5.58 | $302.50 | $55.9K | 0 | 204 |
| AMGN | CALL | TRADE | BEARISH | 06/20/25 | $35.7 | $34.2 | $34.25 | $310.00 | $51.3K | 97 | 0 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGN | 放 | 扫 | 粗鲁的 | 09/20/24 | 15.55 美元 | 14.8 美元 | 15.6 美元 | 300.00 美元 | 173.1 万美元 | 247 | 40 |
| AMGN | 放 | 贸易 | 粗鲁的 | 06/21/24 | 6.25 美元 | 6.05 美元 | 6.2 美元 | 300.00 美元 | 62.0 万美元 | 2.0K | 10 |
| AMGN | 放 | 贸易 | 粗鲁的 | 05/17/24 | 2.53 美元 | 2.31 美元 | 2.45 美元 | 300.00 美元 | 61.2 万美元 | 818 | 767 |
| AMGN | 放 | 扫 | 看涨 | 05/24/24 | 6.45 美元 | 5.5 美元 | 5.58 美元 | 302.50 美元 | 55.9 万美元 | 0 | 204 |
| AMGN | 打电话 | 贸易 | 粗鲁的 | 06/20/25 | 35.7 美元 | 34.2 美元 | 34.25 美元 | 310.00 美元 | 51.3 万美元 | 97 | 0 |
About Amgen
关于安进
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
安进是基于生物技术的人体疗法的领导者。旗舰药物包括红细胞增强剂Epogen和Aranesp、免疫系统增强剂Neupogen和Neulasta以及治疗炎症性疾病的Enbrel和Otezla。安进于2006年推出了其首款癌症疗法Vectibix，并销售强化骨骼的药物Prolia/Xgeva（2010年获得批准）和Evenity（2019年）。对Onyx的收购加强了该公司与Kyprolis合作的治疗肿瘤学产品组合。最近推出的产品包括Repatha（降胆固醇）、Aimovig（偏头痛）、Lumakras（肺癌）和Tezspire（哮喘）。2023年Horizon的收购带来了几种罕见疾病药物，包括甲状腺眼病药物Tepezza。安进的生物仿制药产品组合也在不断增长。
Following our analysis of the options activities associated with Amgen, we pivot to a closer look at the company's own performance.
在分析了与安进相关的期权活动之后，我们将转向仔细研究公司自身的表现。
Current Position of Amgen
安进的现状
- Currently trading with a volume of 852,384, the AMGN's price is up by 0.92%, now at $303.07.
- RSI readings suggest the stock is currently may be overbought.
- Anticipated earnings release is in 85 days.
- AMGN目前的交易量为852,384美元，价格上涨了0.92％，目前为303.07美元。
- RSI读数表明该股目前可能处于超买状态。
- 预计财报将在85天后发布。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Amgen with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险，但也提供了更高利润的潜力。精明的交易者通过持续的教育、战略贸易调整、利用各种指标以及随时关注市场动态来降低这些风险。使用Benzinga Pro了解安进的最新期权交易，以获得实时警报。